KEYNOTE-522: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer

McArthur, H (author)

Cortes, J (author)

Dent, R (author)

show more...

Pusztai, L (author)

Kummel, S (author)

Bergh, J (author)

Denkert, C (author)

Park, YH (author)

Hui, R (author)

Harbeck, N (author)

Takahashi, M (author)

Untch, M (author)

Fasching, PA (author)

Cardoso, F (author)

Andersen, J (author)

Patt, D (author)

Danso, M (author)

Ferreira, M (author)

Mouret-Reynier, MA (author)

Im, SA (author)

Ahn, JH (author)

Gion, M (author)

Baron-Hay, S (author)

Boileau, JF (author)

Zhu, YL (author)

Pan, W (author)

Tryfonidis, K (author)

Karantza, V (author)

O'Shaughnessy, J (author)

Schmid, P (author)

show less...

2022

2022

English.

In: ANNALS OF SURGICAL ONCOLOGY. - 1068-9265. ; 29:SUPPL 2, s. 338-338

Related links:

http://kipublication...

• Conference paper (other academic/artistic)